Multicenter iTBS Neuromodulation for PTSD Treatment
NCT: NCT06434766 · RECRUITING
Brief Summary
The proposed study aims to evaluate the efficacy of intermittent theta-burst transcranial magnetic stimulation (iTBS) targeting primary motor cortex (M1) as adjunct treatment for PTSD patients. The primary outcome measure includes changes in PTSD symptom severity, with secondary outcome measures focusing on negative moods improvements, quality of life and social/occupation functioning and functional connectivity of the brain.
Frequently Asked Questions
What is Multicenter iTBS Neuromodulation for PTSD Treatment?
Multicenter iTBS Neuromodulation for PTSD Treatment is a clinical trial registered under NCT06434766. Current status: RECRUITING.
What is the status of NCT06434766?
The current status of NCT06434766 (Multicenter iTBS Neuromodulation for PTSD Treatment) is: RECRUITING.
When did Multicenter iTBS Neuromodulation for PTSD Treatment start?
Multicenter iTBS Neuromodulation for PTSD Treatment started on 2024-10-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.